SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Generic NSAID Causes Fewer Complications
October 19, 2005
 · 
1 min read
Genetown
Ultrasound May Help Dissolve Deadly Blood Clots
October 19, 2005
 · 
1 min read
Lone Star Bio
First Link Found Between Obesity, Inflammation And Vascular Disease
October 19, 2005
 · 
1 min read
Lone Star Bio
Potential “Weak Link” Between Virus And Liver Cancer Discovered
October 19, 2005
 · 
1 min read
Lone Star Bio
Gene’s Mutations Found To Cause Life-Threatening Aortic Disease
October 19, 2005
 · 
1 min read
Lone Star Bio
Engineered Stem Cells Can Home In On Tumors And Deliver Drug Payload In Mice
October 19, 2005
 · 
1 min read
Lone Star Bio
Checking Foot Temperature May Curb Diabetic Sores
October 19, 2005
 · 
1 min read
Lone Star Bio
Texas Viral Meningitis Outbreak Sickens 6
October 19, 2005
 · 
1 min read
BioCapital
Scientists Tout Method Of Attacking Tumors
October 19, 2005
 · 
1 min read
Lone Star Bio
New Protein Associated With Aggressiveness In Breast And Ovarian Cancer
October 19, 2005
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy
February 16, 2026
 · 
3 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
 · 
4 min read
Press Releases
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
February 13, 2026
 · 
11 min read
Press Releases
Medicenna Announces Changes to Board Composition
February 13, 2026
 · 
6 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
February 12, 2026
 · 
1 min read
Press Releases
Tvardi Therapeutics to Participate in Upcoming Investor Conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
 · 
4 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
 · 
5 min read
Load More